Selected research
Industry Research
Tranexamic Acid Industry Research Report 2026
Market perspective
The global Tranexamic Acid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tranexamic Acid is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tranexamic Acid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tranexamic Acid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tranexamic Acid include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tranexamic Acid market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Tranexamic Acid.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tranexamic Acid Market by Company
Venkata Sai Life Sciences
Aquatic Remedies
Taicang Pharmaceutical Factory
Shilpa Medicare Limited
Yangtze River Pharmaceutical Group
Dongting Pharma
Huluwa Pharma
Tranexamic Acid Segment by Type
USP25
BP2000
Others
Tranexamic Acid Segment by Application
Trauma
Craniocerebral Trauma
Menorrhagia
Postpartum Hemorrhage
Surgery
Whitening Cosmetics
Others
Tranexamic Acid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tranexamic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tranexamic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tranexamic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tranexamic Acid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tranexamic Acid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tranexamic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- USP25
- BP2000
- Others
Applications
- Trauma
- Craniocerebral Trauma
- Menorrhagia
- Postpartum Hemorrhage
- Surgery
- Whitening Cosmetics
- Others
Companies covered
- Venkata Sai Life Sciences
- Aquatic Remedies
- Taicang Pharmaceutical Factory
- Shilpa Medicare Limited
- Yangtze River Pharmaceutical Group
- Dongting Pharma
- Huluwa Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Tranexamic Acid by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 USP25
- 2.2.3 BP2000
- 2.2.4 Others
- 2.3 Tranexamic Acid by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Trauma
- 2.3.3 Craniocerebral Trauma
- 2.3.4 Menorrhagia
- 2.3.5 Postpartum Hemorrhage
- 2.3.6 Surgery
- 2.3.7 Whitening Cosmetics
- 2.3.8 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Tranexamic Acid Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Tranexamic Acid Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Tranexamic Acid Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Tranexamic Acid Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tranexamic Acid Production by Manufacturers (2021-2026)
- 3.2 Global Tranexamic Acid Production Value by Manufacturers (2021-2026)
- 3.3 Global Tranexamic Acid Average Price by Manufacturers (2021-2026)
- 3.4 Global Tranexamic Acid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tranexamic Acid Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Tranexamic Acid Manufacturers, Product Type & Application
- 3.7 Global Tranexamic Acid Manufacturers Established Date
- 3.8 Global Tranexamic Acid Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Venkata Sai Life Sciences
- 4.1.1 Venkata Sai Life Sciences Tranexamic Acid Company Information
- 4.1.2 Venkata Sai Life Sciences Tranexamic Acid Business Overview
- 4.1.3 Venkata Sai Life Sciences Tranexamic Acid Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Venkata Sai Life Sciences Product Portfolio
- 4.1.5 Venkata Sai Life Sciences Recent Developments
- 4.2 Aquatic Remedies
- 4.2.1 Aquatic Remedies Tranexamic Acid Company Information
- 4.2.2 Aquatic Remedies Tranexamic Acid Business Overview
- 4.2.3 Aquatic Remedies Tranexamic Acid Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Aquatic Remedies Product Portfolio
- 4.2.5 Aquatic Remedies Recent Developments
- 4.3 Taicang Pharmaceutical Factory
- 4.3.1 Taicang Pharmaceutical Factory Tranexamic Acid Company Information
- 4.3.2 Taicang Pharmaceutical Factory Tranexamic Acid Business Overview
- 4.3.3 Taicang Pharmaceutical Factory Tranexamic Acid Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Taicang Pharmaceutical Factory Product Portfolio
- 4.3.5 Taicang Pharmaceutical Factory Recent Developments
- 4.4 Shilpa Medicare Limited
- 4.4.1 Shilpa Medicare Limited Tranexamic Acid Company Information
- 4.4.2 Shilpa Medicare Limited Tranexamic Acid Business Overview
- 4.4.3 Shilpa Medicare Limited Tranexamic Acid Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Shilpa Medicare Limited Product Portfolio
- 4.4.5 Shilpa Medicare Limited Recent Developments
- 4.5 Yangtze River Pharmaceutical Group
- 4.5.1 Yangtze River Pharmaceutical Group Tranexamic Acid Company Information
- 4.5.2 Yangtze River Pharmaceutical Group Tranexamic Acid Business Overview
- 4.5.3 Yangtze River Pharmaceutical Group Tranexamic Acid Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Yangtze River Pharmaceutical Group Product Portfolio
- 4.5.5 Yangtze River Pharmaceutical Group Recent Developments
- 4.6 Dongting Pharma
- 4.6.1 Dongting Pharma Tranexamic Acid Company Information
- 4.6.2 Dongting Pharma Tranexamic Acid Business Overview
- 4.6.3 Dongting Pharma Tranexamic Acid Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Dongting Pharma Product Portfolio
- 4.6.5 Dongting Pharma Recent Developments
- 4.7 Huluwa Pharma
- 4.7.1 Huluwa Pharma Tranexamic Acid Company Information
- 4.7.2 Huluwa Pharma Tranexamic Acid Business Overview
- 4.7.3 Huluwa Pharma Tranexamic Acid Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Huluwa Pharma Product Portfolio
- 4.7.5 Huluwa Pharma Recent Developments
5 Global Tranexamic Acid Production by Region
- 5.1 Global Tranexamic Acid Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tranexamic Acid Production by Region: 2021-2032
- 5.2.1 Global Tranexamic Acid Production by Region: 2021-2026
- 5.2.2 Global Tranexamic Acid Production Forecast by Region (2027-2032)
- 5.3 Global Tranexamic Acid Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Tranexamic Acid Production Value by Region: 2021-2032
- 5.4.1 Global Tranexamic Acid Production Value by Region: 2021-2026
- 5.4.2 Global Tranexamic Acid Production Value Forecast by Region (2027-2032)
- 5.5 Global Tranexamic Acid Market Price Analysis by Region (2021-2026)
- 5.6 Global Tranexamic Acid Production and Value, YOY Growth
- 5.6.1 North America Tranexamic Acid Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Tranexamic Acid Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Tranexamic Acid Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Tranexamic Acid Production Value Estimates and Forecasts (2021-2032)
6 Global Tranexamic Acid Consumption by Region
- 6.1 Global Tranexamic Acid Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Tranexamic Acid Consumption by Region (2021-2032)
- 6.2.1 Global Tranexamic Acid Consumption by Region: 2021-2026
- 6.2.2 Global Tranexamic Acid Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Tranexamic Acid Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Tranexamic Acid Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Tranexamic Acid Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Tranexamic Acid Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Tranexamic Acid Production by Type (2021-2032)
- 7.1.1 Global Tranexamic Acid Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Tranexamic Acid Production Market Share by Type (2021-2032)
- 7.2 Global Tranexamic Acid Production Value by Type (2021-2032)
- 7.2.1 Global Tranexamic Acid Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Tranexamic Acid Production Value Market Share by Type (2021-2032)
- 7.3 Global Tranexamic Acid Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Tranexamic Acid Production by Application (2021-2032)
- 8.1.1 Global Tranexamic Acid Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Tranexamic Acid Production Market Share by Application (2021-2032)
- 8.2 Global Tranexamic Acid Production Value by Application (2021-2032)
- 8.2.1 Global Tranexamic Acid Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Tranexamic Acid Production Value Market Share by Application (2021-2032)
- 8.3 Global Tranexamic Acid Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Tranexamic Acid Value Chain Analysis
- 9.1.1 Tranexamic Acid Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Tranexamic Acid Production Mode & Process
- 9.2 Tranexamic Acid Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Tranexamic Acid Distributors
- 9.2.3 Tranexamic Acid Customers
10 Global Tranexamic Acid Analyzing Market Dynamics
- 10.1 Tranexamic Acid Industry Trends
- 10.2 Tranexamic Acid Industry Drivers
- 10.3 Tranexamic Acid Industry Opportunities and Challenges
- 10.4 Tranexamic Acid Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst